There was a statistically significant decrease in NKp46 (NCR1) expression in ALL subjects at diagnosis (p < 0.005) and at conclusion of induction chemotherapy (p < 0.05) when compared to the healthy subjects, as shown in Figure 2. Here, NCR1 is linked to acute lymphoblastic leukemia.